## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-06-07T07:25:39.819Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "ECG and ACLS Tutor"
developer_entity: "Anesoft Corporation"
bundle_id: "com.anesoftcorporation.ecgandaclstutor"
app_store_id: "6502144488"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2025-08-07"
report_date: "2026-06-07"
last_verified: "2026-06-07"
report_version: "24.5.8"
total_reviews: 6
overall_rating: 4.33
confidence: "low"
confidence_score: 0.3
data_age_days: 0
intelligence_version: 3
nemesis: "Full Code Medical Simulation"
competitor_count: 7
tags: ["medical", "paid", "mobile app", "app review", "app analysis", "healthcare", "professionals", "students"]
canonical_url: "https://marlvel.ai/apps/com-anesoftcorporation-ecgandaclstutor"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# ECG and ACLS Tutor App Audit

## TL;DR {#tldr}

- **Category**: Medical · Paid
- **Signal**: Rating 4.33

> **TL;DR:** ECG and ACLS Tutor is a medical app by Anesoft Corporation, rated 4.33/5 by 6 users, available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** ECG and ACLS Tutor is a medical app by Anesoft Corporation.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.33/5 (6 reviews) |
| **Category** | Medical |
| **Developer** | Anesoft Corporation |
| **Pricing** | Paid |
| **Platforms** | iOS & Android |
| **Confidence** | Low (0.3/1.0) |
| **Data Age** | 25d |

## Metadata & Market Performance
- **Publisher:** Anesoft Corporation
- **Category:** Medical
- **Target Audience:** Healthcare professionals and students preparing for American Heart Association Advanced Cardiac Life Support certification.
- **Platforms:** iOS & Android
- **Version Audited:** 24.5.8
- **Audit Date:** 2026-06-07
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.3/1.0)
- **App Store ID (iOS):** 6502144488
- **Bundle ID:** com.anesoftcorporation.ecgandaclstutor
- **Google Play ID:** com.anesoftcorporation.ecgandaclstutor
- **Performance Trend:** Mixed
- **Data Window:** Analysis based on signals collected up to 2026-06-07
- **Short Description:** ECG modules improve rhythm ID. ACLS is a simulator for cardiac arrest scenarios.

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** ECG and ACLS Tutor is a medical training app for rhythm identification and cardiac arrest simulation on iOS and Android.
**Why users hire it:** Users hire the app to rehearse high-stakes resuscitation skills in a low-cost, portable format that mimics real-world clinical monitors.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] ECG Rhythm Modules:** Four-module training system covering rhythm identification, wave analysis, and interval measurement using dynamic screen-sweeping waveforms.
  * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior.
- **[Differentiator] ACLS Megacode Simulator:** Screen-based simulation of cardiac arrest scenarios requiring patient evaluation, rhythm diagnosis, and team leadership.
- **[Standard] AHA Guideline Integration:** Simulation logic updated to reflect 2024 American Heart Association treatment protocols for cardiac resuscitation.
  * *User Intent:* Users need clear guidance to understand and adopt the product quickly.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

The app holds a #24 Medical category rank in the US, but the lack of Android ratings (0) indicates a significant platform-specific discovery failure. The $0.99 price point serves as a volume-capture mechanism, yet it creates a revenue ceiling that prevents investment in high-fidelity simulation features.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** $0.99 one-time purchase
- **Price:** iOS: $0.99 | Android: $0.99
- **Analysis:** Low-friction, one-time purchase model anchored at $0.99 to maximize volume among medical students and trainees.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- 2024 AHA guideline compliance maintains category authority
- Dynamic waveform display provides clinical training advantage
- Low-friction $0.99 price point maximizes student volume

**Critical Frictions:**
- Zero Android rating count indicates poor visibility
- One-time purchase model restricts long-term revenue
- Lack of social-learning features limits user retention

**Growth Levers:**
- Expansion into institutional B2B nursing school licensing
- Integration of wearable-based heart rate data
- Development of multi-user team simulation modes

**Market Threats:**
- Full Code's immersive engine siphons professional users
- AI-driven clinical tools shift focus toward intervention
- Subscription-based competitors capture higher lifetime value

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The app expanded its core functionality to include ACLS simulation and guideline compliance, but identified critical Android discovery failures and revenue limitations.

**Overall trend**: Mixed
**Compared at**: 2026-06-07

### High-impact changes
- **[Added] ACLS Megacode Simulator** (features) — Added a screen-based simulation for cardiac arrest scenarios, moving the app beyond static rhythm identification.
- **[Added] Android Discovery Failure** (swot) — Identified zero Android ratings as a critical acquisition failure, contrasting with the previous lack of platform-specific data.
- **[Added] Pricing Model Formalization** (pricing) — Explicitly identified the $0.99 one-time purchase as a revenue ceiling that prevents investment in high-fidelity features.

### Medium-impact changes
- **[Added] AHA Guideline Integration** (features) — Integrated 2024 American Heart Association protocols to maintain clinical authority.
- **[Shifted] Market Positioning** (positioning) — Shifted from a general study aid to a specialized tool for high-stakes code blue team preparation.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### ECG and ACLS Tutor vs Full Code Medical Simulation — Head to Head
- **[Full Code Medical Simulation](https://marlvel.ai/apps/com-minerva-medical-fullcode)** by Full Code Medical Inc.: This is the dominant market leader in the medical simulation niche, offering high-fidelity interactive scenarios that directly compete with the target's ACLS simulator.
  - **Moat strength:** High — sustainable advantage over 12 months
  - **Key differences:**
    - Provides high-fidelity, interactive virtual patient scenarios that simulate real-world clinical decision-making environments.
    - Maintains a consistent release cadence of five updates in six months, ensuring clinical content remains current.
    - Focuses on immersive, gamified simulation rather than static rhythm identification modules found in the target app.
  - **Where ECG and ACLS Tutor wins:**
    - ✅ Offers a more focused, lightweight tool specifically tailored for rapid ACLS certification exam preparation.
    - ✅ Provides a lower barrier to entry with a simple, direct pricing model for quick skill maintenance.
  - **Where Full Code Medical Simulation wins:**
    - ❌ Delivers a comprehensive, high-fidelity simulation engine that offers deeper clinical immersion than static modules.
    - ❌ Maintains a large, active user base that provides social proof and community-driven clinical feedback loops.
  - **Verdict:** The target app must pivot toward high-fidelity simulation or double down on its niche as a rapid, low-cost exam prep tool to avoid being eclipsed by Full Code's immersive platform.

### Contenders (Strong Challengers)
- **[Vargo Anesthesia Mega App](https://marlvel.ai/apps/com-insertnamehere-vargomasterapp)** by Vargo Anesthesia Inc [Moat: High]: A massive, high-utility clinical reference tool that captures the same professional audience seeking advanced cardiac and procedural support.
  - Integrates a vast library of anesthesia-specific clinical calculators and reference guides beyond simple rhythm identification.
  - Maintains high-velocity development with eight releases in the last six months to keep clinical data current.
- **[IMAIOS e-Anatomy](https://marlvel.ai/apps/com-imaios-eanatomy)** by IMAIOS [Moat: Medium]: A specialized medical reference tool that dominates the anatomy education space, serving as a primary resource for the same medical professional demographic.
  - Features an extensive, interactive atlas of human anatomy that serves as a foundational reference for all medical students.
  - Aggressive update schedule with nine releases in the last six months ensures platform stability and content expansion.

### Peers (What They Do Better)
- **[NCLEX RN Mastery Exam - 2026](https://marlvel.ai/apps/com-higherlearning-nclex)** by Higher Learning Technologies: Directly competes for the same student audience focused on passing high-stakes medical certification exams.
  - Utilizes a comprehensive question bank and adaptive learning technology to personalize the exam preparation experience.
  - Provides detailed performance analytics that allow users to track their readiness for the actual certification exam.
- **[Saunders Comp Review NCLEX RN](https://marlvel.ai/apps/com-medpresso-testzapp-crnclexrn)** by Skyscape Medpresso Inc: A trusted, brand-name educational resource that serves as a primary alternative for nursing students preparing for board exams.
  - Leverages established, high-quality textbook content converted into a mobile-first, interactive testing format.
  - Focuses on deep, content-rich explanations that help students understand the 'why' behind clinical answers.

### New Kids on the Block (What's Innovative)
- **[Sword Health: AI Care](https://marlvel.ai/apps/com-swordhealth-guarda-ios)** by Sword Health, Inc: An emerging threat utilizing AI-driven clinical care, showing high velocity with 11 releases in the last six months.
- **[mySugr - Diabetes Tracker Log](https://marlvel.ai/apps/com-mysugr-companion-mysugr)** by mySugr GmbH: A rapidly evolving health management tool with nine releases in the last six months, demonstrating strong commitment to user-centric clinical data.

<!-- /section:rivals -->
<!-- section:momentum -->
## App Momentum (Steady) {#momentum}

- Updated simulation logic for 2024 guidelines.
- Shipped Android 15 compatibility updates.

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

ECG and ACLS Tutor is an established medical app that is a paid app.
With a 4.33/5 rating from 6 reviews, it shows polarized user reception.

<!-- speakable-start -->
> **Bottom Line:** The app maintains clinical relevance through timely AHA guideline updates, but the lack of a recurring revenue model and Android visibility leaves it vulnerable to high-fidelity competitors, so the PM must prioritize institutional B2B licensing to escape the consumer price ceiling.
<!-- speakable-end -->

**Best for:** Healthcare professionals and students preparing for American Heart Association Advanced Cardiac Life Support certification.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] [HIGH IMPACT] Audit Android discovery funnel because zero ratings suggest a broken install path → recover Android user base — *The Android platform has 0 ratings despite being a live store presence, signaling a critical acquisition failure.* _(trade-off: deprioritize Pause the planned iOS UI refresh — Android visibility is a higher-impact revenue risk.)_
- [ ] [PIVOT] [HIGH IMPACT] Ship B2B institutional pilot because the $0.99 price ceiling limits growth → unlock recurring revenue — *The consumer-paid model is capped at $0.99, necessitating a shift to institutional volume to scale.* _(trade-off: deprioritize Deprioritize the rhythm-module content expansion — institutional sales require stability, not new features.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- High-fidelity interactive virtual patient scenarios (available in Full Code Medical Simulation)
- Social-learning community feedback loops (available in Full Code Medical Simulation)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Mixed

The medical simulation market is consolidating around high-fidelity, subscription-based platforms that offer deeper clinical immersion than static rhythm tools. ECG and ACLS Tutor remains exposed to this shift, as its one-time purchase model provides insufficient capital to fund the transition toward interactive, multi-user simulation.

- 🟢 The latest update aligns simulation logic with 2024 AHA guidelines, ensuring the app remains a compliant tool for certification prep.
- 🔴 Zero Android ratings suggest a critical discovery failure, which prevents the app from competing for the broader mobile medical student market.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.33/5 |
| Total Reviews | 6 |
| Confidence | Low |
| Pricing Model | Paid |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Mixed |
| Outlook | Mixed |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **ECG and ACLS Tutor** (this app) | 4.33/5 | N/A | Anesoft Corporation |
| [Sword Health: AI Care](https://marlvel.ai/apps/com-swordhealth-guarda-ios) | 4.7/5 | N/A | Sword Health, Inc |
| [NCLEX RN Mastery Exam - 2026](https://marlvel.ai/apps/com-higherlearning-nclex) | 4.8/5 | N/A | Higher Learning Technologies |
| [Saunders Comp Review NCLEX RN](https://marlvel.ai/apps/com-medpresso-testzapp-crnclexrn) | 4.8/5 | N/A | Skyscape Medpresso Inc |
| [IMAIOS e-Anatomy](https://marlvel.ai/apps/com-imaios-eanatomy) | 4.9/5 | N/A | IMAIOS |
| [Full Code Medical Simulation](https://marlvel.ai/apps/com-minerva-medical-fullcode) | 4.8/5 | N/A | Full Code Medical Inc. |

## Company Profile
- **Developer:** Anesoft Corporation
- **Website:** [https://anesoft.com/ecg-rhythms-and-acls-cases/](https://anesoft.com/ecg-rhythms-and-acls-cases/)
- **Social:** [Facebook](https://www.facebook.com/anesoftcorporation)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/ecg-and-acls-tutor/id6502144488?uo=2)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.anesoftcorporation.ecgandaclstutor&hl=en&gl=us)
- **Dev Site:** [Official Website](https://anesoft.com/ecg-rhythms-and-acls-cases/)
- **Sources:** Developer website content, About us / company information, App store metadata.

## Related Intel Reports
- [*Sword Health: AI Care*](https://marlvel.ai/apps/com-swordhealth-guarda-ios) (Sword Health, Inc) — 4.7/5 Rating | N/A Sentiment
- [*NCLEX RN Mastery Exam - 2026*](https://marlvel.ai/apps/com-higherlearning-nclex) (Higher Learning Technologies) — 4.8/5 Rating | N/A Sentiment
- [*Saunders Comp Review NCLEX RN*](https://marlvel.ai/apps/com-medpresso-testzapp-crnclexrn) (Skyscape Medpresso Inc) — 4.8/5 Rating | N/A Sentiment
- [*IMAIOS e-Anatomy*](https://marlvel.ai/apps/com-imaios-eanatomy) (IMAIOS) — 4.9/5 Rating | N/A Sentiment
- [*Full Code Medical Simulation*](https://marlvel.ai/apps/com-minerva-medical-fullcode) (Full Code Medical Inc.) — 4.8/5 Rating | N/A Sentiment
- [*Vargo Anesthesia Mega App*](https://marlvel.ai/apps/com-insertnamehere-vargomasterapp) (Vargo Anesthesia Inc) — 4.7/5 Rating | N/A Sentiment
- [*mySugr - Diabetes Tracker Log*](https://marlvel.ai/apps/com-mysugr-companion-mysugr) (mySugr GmbH) — 4.7/5 Rating | N/A Sentiment
- [*Move On with AJ*](https://marlvel.ai/apps/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*NYC Employees PPO Plan*](https://marlvel.ai/apps/com-uhg-mobile-nyce) (United HealthCare Services, Inc.) — 4.6/5 Rating | N/A Sentiment
- [*FHO+ Calc*](https://marlvel.ai/apps/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 25 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/com-anesoftcorporation-ecgandaclstutor)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.